Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,296 | 247 | 99.2% |
| Education | $25.46 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $924.22 | 58 | $0 (2024) |
| Gilead Sciences, Inc. | $429.28 | 54 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $273.29 | 19 | $0 (2024) |
| Celgene Corporation | $195.36 | 15 | $0 (2023) |
| PFIZER INC. | $159.93 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $155.71 | 10 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $136.41 | 10 | $0 (2023) |
| Braintree Laboratories, Inc. | $134.63 | 5 | $0 (2023) |
| Allergan Inc. | $128.35 | 9 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $125.45 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $369.85 | 16 | ABBVIE INC. ($124.98) |
| 2023 | $224.98 | 13 | PFIZER INC. ($45.69) |
| 2022 | $486.52 | 37 | ABBVIE INC. ($208.46) |
| 2021 | $342.00 | 25 | Celgene Corporation ($125.50) |
| 2020 | $149.36 | 11 | AbbVie Inc. ($42.68) |
| 2019 | $494.73 | 34 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($111.48) |
| 2018 | $633.55 | 68 | AbbVie, Inc. ($194.16) |
| 2017 | $620.84 | 45 | Gilead Sciences Inc ($188.68) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Immunology | ||||||
| 10/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Education | In-kind items and services | $11.59 | General |
| Category: INFLAM | ||||||
| 09/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: GI | ||||||
| 06/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 02/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Immunology | ||||||
| 01/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Gastroenterology | ||||||
| 01/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: Neuroscience | ||||||
| 11/22/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $19.31 | General |
| 10/10/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/21/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Immunology | ||||||
| 06/16/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/08/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/28/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: GI COLON PREP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 378 | 471 | $73,040 | $48,919 |
| 2022 | 6 | 380 | 514 | $110,855 | $53,890 |
| 2021 | 8 | 453 | 543 | $78,560 | $54,289 |
| 2020 | 9 | 388 | 476 | $67,137 | $41,123 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 242 | $35,762 | $23,831 | 66.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $13,005 | $9,003 | 69.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $9,203 | $6,103 | 66.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 59 | $6,600 | $4,428 | 67.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $5,667 | $3,426 | 60.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $2,412 | $1,843 | 76.4% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 11 | 11 | $390.72 | $284.50 | 72.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 313 | $52,518 | $33,124 | 63.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 100 | 100 | $15,595 | $8,409 | 53.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $21,713 | $5,449 | 25.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $12,148 | $2,941 | 24.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 11 | 11 | $6,002 | $2,420 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 24 | $2,879 | $1,547 | 53.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 209 | $31,106 | $22,297 | 71.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 110 | $11,446 | $8,633 | 75.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 51 | 51 | $11,661 | $7,687 | 65.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 83 | 83 | $10,767 | $7,053 | 65.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 40 | 43 | $7,201 | $4,956 | 68.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 14 | 14 | $5,518 | $3,098 | 56.1% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 17 | 18 | $690.53 | $519.69 | 75.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 15 | 15 | $170.00 | $45.00 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 146 | 218 | $26,771 | $19,433 | 72.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 52 | 52 | $6,355 | $4,448 | 70.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 67 | $5,717 | $4,010 | 70.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 33 | 34 | $15,014 | $3,983 | 26.5% |
About Dr. Patrick Tempera, MD
Dr. Patrick Tempera, MD is a Gastroenterology healthcare provider based in Union, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508830050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Tempera, MD has received a total of $3,322 in payments from pharmaceutical and medical device companies, with $369.85 received in 2024. These payments were reported across 249 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,296).
As a Medicare-enrolled provider, Tempera has provided services to 1,599 Medicare beneficiaries, totaling 2,004 services with total Medicare billing of $198,220. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Union, NJ
- Active Since 02/13/2006
- Last Updated 06/28/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508830050
Products in Payments
- XIFAXAN (Drug) $260.42
- ZEPOSIA (Drug) $195.36
- SKYRIZI (Biological) $179.08
- RINVOQ (Biological) $159.74
- XELJANZ (Drug) $145.55
- Humira (Biological) $128.34
- LINZESS (Drug) $116.99
- Mavyret (Drug) $108.95
- HUMIRA (Biological) $102.73
- STELARA (Biological) $102.54
- Creon (Drug) $93.37
- OCALIVA (Drug) $90.16
- MOTOFEN (Drug) $75.55
- SUTAB (Drug) $59.08
- TREMFYA (Drug) $53.17
- OMVOH (Drug) $50.27
- VOQUEZNA (Drug) $47.58
- ZENPEP (Drug) $47.36
- OCA (Drug) $46.25
- GI GENIUS (Device) $45.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Union
Dr. Kunal Grover, Md, MD
Gastroenterology — Payments: $6,448
Dr. Pradeep Mahal, M.d, M.D
Gastroenterology — Payments: $5,580
Pavan Sachan, M.d, M.D
Gastroenterology — Payments: $4,762
Dr. Michael Viksjo, Md, MD
Gastroenterology — Payments: $4,154
Dr. Dhanasekaran Ramasamy, M.d, M.D
Gastroenterology — Payments: $2,839
Geethan Sivananthan
Gastroenterology — Payments: $2,019